Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04121780 · ClinicalTrials.gov registry record · Phase 2
Growth Hormone Replacement Therapy for Retried Professional Football Players
A Phase 2 study of TBI (Traumatic Brain Injury) and Concussion, Brain, sponsored by Center for Neurological Studies.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT04121780 is a Phase 2 study of TBI (Traumatic Brain Injury) and Concussion, Brain that is actively recruiting participants, run by Center for Neurological Studies. The registered enrollment target is 42 participants, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04121780, a Phase 2 study of TBI (Traumatic Brain Injury) and Concussion, Brain, is actively recruiting participants, sponsored by Center for Neurological Studies.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional football players with growth hormone deficiency (GHD).
Conditions Studied
Interventions
- OTHER Placebo
- BIOLOGICAL Growth Hormone
Study Locations (1)
Michigan
- Center for Neurolgoical Studies (CNS) - Dearborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2026-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04121780
The ClinicalTrials.gov registry entry for NCT04121780 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (75% lower). The listed sponsor is Center for Neurological Studies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04121780 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04121780 about?
NCT04121780 is a clinical study titled "Growth Hormone Replacement Therapy for Retried Professional Football Players". This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional football players with growth hormone deficiency (GHD).
What is the current status of trial NCT04121780?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2019-10-08. Estimated completion is 2026-09.
What conditions does trial NCT04121780 study?
This clinical trial studies the following conditions: TBI (Traumatic Brain Injury), Concussion, Brain, Growth Hormone Deficiency, Hypopituitarism, Sport Injury.
What interventions are being tested in trial NCT04121780?
The interventions under investigation include: Placebo (OTHER), Growth Hormone (BIOLOGICAL).
Who is sponsoring clinical trial NCT04121780?
This trial is sponsored by Center for Neurological Studies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04121780 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for TBI (Traumatic Brain Injury)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy
RECRUITING · Phase 2
-
Autologous Stem Cell Study for Adult TBI (Phase 2b)
ACTIVE NOT RECRUITING · Phase 2
-
Stimulating After Recovery From Traumatic Brain Injury
RECRUITING · Early Phase 1
-
Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
RECRUITING · NA
-
Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury
RECRUITING · NA
-
Evaluation of Well-being Interventions in Adults With TBI
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.